Τα καλύτερα Pharma Market podcast (2024)

1
NHS primary care panel – the GP Contract and Operational Planning Guidance 1:02:14

20d ago1:02:14

1:02:14

What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–25? In this webinar, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) spoke to a…

1
From Battlefields to Boardrooms: Transformative Leadership Secrets in Pharma 21:17

26d ago21:17

21:17

In this episode of Pharma Marketing Playbook, we sit down with Atul Suri, Strategic Business Unit Head at Alembic Pharmaceutical Limited. Atul's remarkable journey spans from his distinguished military service to a leading role in the pharmaceutical industry. He shares his unique perspective on leadership, the importance of adaptability, and how AI…

1
Transforming Pharma : AI, Data Analytics and Ethical Marketing with Industry Leader Thambu Raj Anthuvan 32:40

1M ago32:40

32:40

In this episode of the "Pharma Marketing Playbook" series, Saumya Prakash interviews Thambu Raj Anthuvan, Senior Vice President at USV Private Limited, to explore the dynamic intersection of data analytics and AI in the pharmaceutical industry. Together, they discuss how these cutting-edge technologies are transforming marketing strategies, from di…

1
Revolutionizing HCP Engagement: The Power of AI-Driven Solutions in Pharma 36:31

1M ago36:31

36:31

Unlock the power of AI in pharma marketing with our latest episode featuring industry veteran Amaninder Singh Dhillon. From his journey as a trainee to a franchise lead at AstraZeneca, Dhillon shares invaluable insights on leveraging AI for personalized HCP engagement. In this episode, we explore: How data digitization forms the backbone of AI-driv…

1
Evolving landscape of personalized Pharma Marketing with Dr. Kavita Lamror 27:58

1M ago27:58

27:58

Explore the dynamic shift from traditional to digital marketing strategies in the pharmaceutical sector that is being triggered and drive by GenAI. Join us for a fascinating conversation with Dr. Kavita Lamror, a leading expert in real-world evidence and digital transformation at Maxis Clinical Sciences. In this episode, Dr. Kavita delves into how …

1
From Lab Coats to Boardrooms, Decoding Pharma's Global Marketing Evolution 33:26

2M ago33:26

33:26

Can you imagine how exclusivity showcased the critical importance of adaptable strategies in the pharmaceutical industry? In this episode, embark on an illuminating journey through the evolution of pharmaceutical marketing as your host Soumya Prakash engages in a thought-provoking dialogue with industry luminary Salil Kallianpur. In this podcast Mr…

1
Engage NHS healthcare decision-makers with RWD 20:55

2M ago20:55

20:55

Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted par…

1
From Data to Diagnosis How AI is Shaping Pharma Marketing 26:25

2M ago26:25

26:25

Is AI the game-changer the pharmaceutical industry has been waiting for? Join your host Saumya Prakash as she unpacks this pressing question with Gauri Chaudhary, the co-founder of Brand Inner World and the author of "The Perfect Pill: 10 Steps to Build a Strong Healthcare Brand." Gain a new perspective as Gauri categorizes the industry into three …

1
Pharma Marketing’s Evolution from Manual Arithmetic to Artificial Intelligence 26:05

3M ago26:05

26:05

Ever wondered how the pharmaceutical industry transitioned from manual records to cutting-edge AI solutions? In this episode, gain a deep understanding of this evolution as your host Saumya Prakash stirs up an enlightening conversation with Mr. Vivek Hattangadi, who brings nearly 50 years of industry wisdom. Listen in as Mr. Vivek recounts the tran…

1
Market access and reimbursement in Canada – changes at CADTH 47:43

3M ago47:43

47:43

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ott…

1
Transforming Pharma Marketing with AI: A Deep Dive with Ganesh Chakkarwar 20:50

4M ago20:50

20:50

What if artificial intelligence could revolutionize the way we market and treat health conditions? Join us as we welcome Ganesh Chakkarwar takes us on a fascinating journey from the early days of transitioning from physical to digital processes, right up to his current focus on incorporating AI into pharma marketing. Sparked by a capstone project o…

1
Rare Disease market access in the MENA and Nordic regions 59:10

5M ago59:10

59:10

Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored o…

1
How does funding flow in NHSE Regions? 1:00:15

6M ago1:00:15

1:00:15

Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders? We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored fi…

1
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024) 1:02:06

6M ago1:02:06

1:02:06

What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation? Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mte…

1
De-mystifying health economic model classifications and structures 1:00:28

6M ago1:00:28

1:00:28

What is health economic evaluation and which modelling approaches can be used to support market access activities? In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDon…

1
Evidence strategy for Medical Technologies and Diagnostics 53:24

7M ago53:24

53:24

Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be approp…

1
How to set your Pharma or Medtech product up for success in the US market 43:06

7M ago43:06

43:06

How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market. Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (…

1
Data-Driven Decisions: Transforming Pharma Sales 29:37

7M ago29:37

29:37

How can you personalize your messaging to physicians for greater prescription intent? What are people saying about your brand? How can you make your marketing efforts more precise and effective? These and many more questions are answered on this podcast, which is here to serve as a playbook for all your pharma marketing needs. Don’t be left behind …

1
What's happening with specialised commissioning in the NHS? 1:00:08

8M ago1:00:08

1:00:08

What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty? Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to expl…

1
Integrated care in NHS Wales – what can England learn from its neighbour? 56:24

9M ago56:24

56:24

What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and th…

1
Market access in Italy: Reforms at AIFA 43:36

10M ago43:36

43:36

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA). We explore: - The nature of the Ita…

1
PR & Communication Agency GenAI Playbook: Decoding trends and best practices 18:46

10M ago18:46

18:46

Get ready to unveil the intriguing intersection of AI and medical communication in an immersive conversation with Vikram Kumar, the visionary CEO of Multiplier AI as he is hosted by Saumya Prakash on Pharma Marketing Playbook. Want to outshine your competitors and make your mark in the fast-evolving landscape of AI? This episode promises to equip y…

1
Unmet need in NHS primary care – How can industry best support PCN leaders? 1:00:44

10M ago1:00:44

1:00:44

Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond. Former ‘GP of the year’ and strategic influencer over prim…

1
Data Insight Playbook: Tools and Training for marketing effectiveness 24:29

11M ago24:29

24:29

Listen in as podcast host Saumya Prakash uncovers the world of pharma marketing and analytics with our guest Mr. Praveen Mathur, Vice President, Analytics, Amp Idea, Inc. With a wealth of experience spanning over three decades, Mr. Praveen provides an insightful perspective on how AI and data have revolutionized pharma marketing. Some of the key as…

1
Population health management: a community effort across health and life sciences 1:04:01

11M ago1:04:01

1:04:01

How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s popu…

1
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access 39:54

11M ago39:54

39:54

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access? In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of op…

1
6 areas of UK health policy for Medtech to pay attention to 1:01:49

12M ago1:01:49

1:01:49

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for…

1
This is the Pharma Marketing Playbook: Data, GenAI, and Beyond 1:26

12M ago1:26

1:26

Welcome to the epicenter of innovation, where pharma marketing meets Data, GenAI, Social intelligence, Influencer Marketing, and Scientific listening. On this podcast, there is a playbook for every pharma marketing need of yours! Meet your host: Saumya Prakash is an accomplished entrepreneur and tech enthusiast, specializing in AI and IT Software w…

1
Organizational Design: How Can Pharma Keep Optimizing As Everything Business Keeps Changing 23:36

1y ago23:36

23:36

Pharma companies are highly matrixed organizations, which presents challenges in handoffs, overlaps between roles and functions, access to data and accountability of who owns and acts on this data in a timely manner. Therefore, instigating change at an organizational level is difficult, and takes much longer than anticipated. This podcast will shar…

1
Market access in the German speaking markets 57:59

1y ago57:59

57:59

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets. Clare and Stefan discuss: …

1
The role of nursing in driving digital change in the NHS 54:50

1y ago54:50

54:50

How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation? Prof. Phil Richardson (Chair and C…

1
Market access for digital therapies and digital medicines 42:18

1y ago42:18

42:18

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcome…

1
Horizon Therapeutics' Experiences with Executing Multiple Highly Innovative Campaigns Simultaneously to Challenge Disease State Misperceptions, Create Urgency and Change Treatment Behaviors 14:24

1+ y ago14:24

14:24

Toxic Portraits: Gout is traditionally viewed as a low-priority disease with misperceptions driving the narrative. To change those misperceptions, we must be creative and bring the impact of this condition to the forefront. Toxic Portraits provide an innovative way to look at a disease state often overlooked. This entirely different approach to cre…

1
A global market access journey in cannabinoid pharmaceuticals 53:47

1+ y ago53:47

53:47

What does it take to bring a cannabinoid pharmaceutical to market? We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons …

1
Primary Care and ICBs – what is the next step in the integration journey? 1:01:17

1+ y ago1:01:17

1:01:17

How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted? Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Pract…

1
Data-led transformation in the NHS - partnering to optimise patient care 1:02:35

1+ y ago1:02:35

1:02:35

Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care? Prof. Phil Richardson (Chair and Chief Innovation Officer, …

1
Innovating for better health – research, collaboration and innovation in the NHS 57:56

1+ y ago57:56

57:56

How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them? Prof Phil Richa…

1
Pharma Marketers Need AI Now: How to deliver a truly personalized, omnichannel experience for your patients, with William Grambley, CEO of Allazo Health 25:00

1+ y ago25:00

25:00

Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged. Plus, given today’s budget realities, you’re likely being asked to achieve more with less. In this podcast, William…

1
Healthcare, economics and society – unlocking NHS collaboration 59:23

1+ y ago59:23

59:23

Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits? Prof Phil Richardson (Chair and Chief Innovation Officer, Mte…

1
Specialised Commissioning in the NHS – What do you need to know now 1:00:34

1+ y ago1:00:34

1:00:34

The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commi…

1
Why are we waiting? - Pressures facing the NHS and how to deliver change 1:00:47

2y ago1:00:47

1:00:47

With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovat…

1
Priority setting in primary care - NHS insights 59:35

2y ago59:35

59:35

How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care? Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. In this episode, we…

1
Integrated Care Systems go live in the NHS - reflections after 3 weeks 1:00:21

2y ago1:00:21

1:00:21

On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the key priorities for NHS decision-makers and what is getting in the way of change? How can Pharma and Medtech support their NHS customers as they implem…

1
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role 1:00:46

2y ago1:00:46

1:00:46

What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN). They explore the origins of the …

1
Transforming systems and care pathways for an integrated NHS 1:00:47

2+ y ago1:00:47

1:00:47

As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations? Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, C…

1
What's Ahead for 1st and 3rd Party Data 31:31

2+ y ago31:31

31:31

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into marketer's next steps after Google phases out 3rd party cookies in 2023.

1
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers 39:25

2+ y ago39:25

39:25

Our experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when…

1
Pharma & Modular Content: A Deeper Dive 26:41

2+ y ago26:41

26:41

Tune in to this episode of the Pharma Marketing Podcast for a deeper dive into pharma and modular content, with Ryan Rosenberg, Director Omnichannel Capabilities @ Sanofi, who shared his insights on making modular content work and why pharma is the perfect candidate for it.Από τον pharma marketing network

1
Cultural Competence for Global Marketing 22:49

2+ y ago22:49

22:49

Tune in to this episode of the Pharma marketing Podcast, with our guest Wendy Pease, President of Rapport International and the author of The Language of Global Marketing for a conversation on why pharma should be thinking global from the start, addressing how to keep a consistent brand globally, and the many things that need to be considered when …

1
Population to Person: How will the NHS translate population health management into impactful, person-centred service change? 56:04

2+ y ago56:04

56:04

What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients? Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). St…

Podcasts που αξίζει να ακούσετε

Pharma Market Podcasts

Podcasts που αξίζει να ακούσετε

Οδηγός γρήγορης αναφοράς